Clinical Trial Update: KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 multiple-dose study of KN057 in patients with Hemophilia A or Hemophilia B (with or without inhibitors) is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• KN057

Snippet

Sponsor: Suzhou Alphamab Co., Ltd. | Conditions: Hemophilia a and B | Phase 2 | Status: NOT_YET_RECRUITING